MFN2 and prediabetes syndrome: However, mRNA expression of MFN2, PARKIN, and LC3-II were found to be significantly decreased in subjects with NDT2DM and ADT2DM as compared to the controls and subjects with prediabetes (p < 0.05) (Figures 3C–E).